308 related articles for article (PubMed ID: 15737568)
1. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
[TBL] [Abstract][Full Text] [Related]
2. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Gao XD; Chen YR
Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
Gao XD; Chen YR
Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
[TBL] [Abstract][Full Text] [Related]
6. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
8. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
9. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
10. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z; Koeneman KS; Corey DR
Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
[TBL] [Abstract][Full Text] [Related]
11. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of anti-sense human telomerase reverse transcriptase (hTERT) retroviral vector on lung cancer cells].
Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W
Ai Zheng; 2004 May; 23(5):545-9. PubMed ID: 15142451
[TBL] [Abstract][Full Text] [Related]
13. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.
Schindler A; Fiedler U; Meye A; Schmidt U; Füssel S; Pilarsky C; Herrmann J; Wirth MP
Int J Oncol; 2001 Jul; 19(1):25-30. PubMed ID: 11408918
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of telomerase with hTERT antisense enhances TNF-alpha-induced apoptosis in prostate cancer cells PC3].
Gao XD; Chen YR
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):723-6. PubMed ID: 17918713
[TBL] [Abstract][Full Text] [Related]
16. [Antisense human telomerase reverse transcriptase inhibits leukemia cell proliferation in vitro].
Sun LB; Li CR; Wen JM; Wang GB; Zhang M; Yang J; Li RX
Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):521-4. PubMed ID: 15151822
[TBL] [Abstract][Full Text] [Related]
17. A novel human cell culture model for the study of familial prostate cancer.
Yasunaga Y; Nakamura K; Ewing CM; Isaacs WB; Hukku B; Rhim JS
Cancer Res; 2001 Aug; 61(16):5969-73. PubMed ID: 11507036
[TBL] [Abstract][Full Text] [Related]
18. TERT regulates cell survival independent of telomerase enzymatic activity.
Cao Y; Li H; Deb S; Liu JP
Oncogene; 2002 May; 21(20):3130-8. PubMed ID: 12082628
[TBL] [Abstract][Full Text] [Related]
19. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
20. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S; Kyo S; Banerjee PP
Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
